Bedtime insulin glargine or bedtime neutral protamine lispro combined with sulfonylurea and metformin in type 2 diabetes. A randomized, controlled trial
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Insulin glargine (Primary) ; Insulin neutral protamine lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Oct 2008 Results published in the Annals of Internal Medicine
- 21 Oct 2008 Primary endpoint 'Proportion of glycosylated haemoglobin' has not been met based on results published in Annals of Internal Medicine.
- 11 Apr 2008 New trial record.